Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior Therapy | 12 | 2020 | 146 | 3.680 |
Why?
|
| Counseling | 12 | 2020 | 189 | 3.330 |
Why?
|
| Mass Screening | 13 | 2020 | 678 | 2.350 |
Why?
|
| Primary Health Care | 13 | 2020 | 770 | 2.040 |
Why?
|
| Advisory Committees | 7 | 2022 | 113 | 1.830 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 615 | 1.390 |
Why?
|
| Cardiovascular Diseases | 6 | 2022 | 599 | 1.270 |
Why?
|
| Depression | 7 | 2019 | 506 | 1.240 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2020 | 54 | 1.220 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 19 | 1.130 |
Why?
|
| Sexual Behavior | 2 | 2020 | 124 | 1.090 |
Why?
|
| Humans | 60 | 2022 | 17822 | 1.000 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 201 | 0.950 |
Why?
|
| Health Behavior | 5 | 2020 | 360 | 0.940 |
Why?
|
| Weight Loss | 3 | 2018 | 305 | 0.880 |
Why?
|
| United States | 18 | 2022 | 4007 | 0.860 |
Why?
|
| Feces | 3 | 2020 | 80 | 0.840 |
Why?
|
| Suicide | 3 | 2013 | 124 | 0.840 |
Why?
|
| Minerals | 1 | 2022 | 10 | 0.800 |
Why?
|
| Prescription Drugs | 2 | 2020 | 31 | 0.790 |
Why?
|
| Anti-Obesity Agents | 3 | 2018 | 18 | 0.780 |
Why?
|
| Antidepressive Agents | 4 | 2019 | 156 | 0.770 |
Why?
|
| Vitamins | 1 | 2022 | 64 | 0.770 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 434 | 0.730 |
Why?
|
| Adult | 28 | 2022 | 7708 | 0.680 |
Why?
|
| Health Education | 1 | 2020 | 111 | 0.660 |
Why?
|
| Exercise | 3 | 2020 | 495 | 0.650 |
Why?
|
| Risk Reduction Behavior | 3 | 2020 | 108 | 0.640 |
Why?
|
| Adolescent | 22 | 2020 | 3690 | 0.640 |
Why?
|
| Health Risk Behaviors | 1 | 2018 | 6 | 0.630 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 373 | 0.620 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 158 | 0.620 |
Why?
|
| Obesity Management | 1 | 2018 | 4 | 0.620 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 55 | 0.590 |
Why?
|
| Preventive Health Services | 4 | 2021 | 160 | 0.570 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 213 | 0.560 |
Why?
|
| Female | 32 | 2020 | 12780 | 0.560 |
Why?
|
| Neoplasms | 1 | 2022 | 445 | 0.560 |
Why?
|
| Asthma | 11 | 2007 | 387 | 0.510 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 85 | 0.510 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 513 | 0.490 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 186 | 0.470 |
Why?
|
| Male | 26 | 2020 | 10145 | 0.470 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2015 | 228 | 0.470 |
Why?
|
| Obesity | 3 | 2018 | 842 | 0.460 |
Why?
|
| Pregnancy | 7 | 2020 | 1529 | 0.390 |
Why?
|
| Psychotherapy | 4 | 2020 | 59 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 321 | 0.360 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 329 | 0.350 |
Why?
|
| Aspirin | 3 | 2016 | 63 | 0.350 |
Why?
|
| Primary Prevention | 2 | 2022 | 73 | 0.320 |
Why?
|
| Middle Aged | 18 | 2020 | 8020 | 0.300 |
Why?
|
| Stomach | 1 | 2008 | 4 | 0.300 |
Why?
|
| Laparoscopy | 1 | 2008 | 49 | 0.290 |
Why?
|
| Gastric Bypass | 1 | 2008 | 71 | 0.280 |
Why?
|
| Child | 8 | 2020 | 2497 | 0.270 |
Why?
|
| Aged | 12 | 2020 | 6173 | 0.270 |
Why?
|
| Young Adult | 3 | 2020 | 2464 | 0.270 |
Why?
|
| Risk Assessment | 6 | 2014 | 1103 | 0.270 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 120 | 0.260 |
Why?
|
| Incidence | 5 | 2020 | 1269 | 0.260 |
Why?
|
| Hypertension | 3 | 2020 | 505 | 0.240 |
Why?
|
| Overweight | 4 | 2017 | 270 | 0.240 |
Why?
|
| Surveys and Questionnaires | 8 | 2020 | 1323 | 0.230 |
Why?
|
| Age Factors | 3 | 2020 | 923 | 0.230 |
Why?
|
| Pre-Eclampsia | 2 | 2014 | 44 | 0.220 |
Why?
|
| Dietary Supplements | 2 | 2022 | 87 | 0.210 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1219 | 0.210 |
Why?
|
| Vitamin A | 1 | 2022 | 14 | 0.200 |
Why?
|
| beta Carotene | 1 | 2022 | 17 | 0.200 |
Why?
|
| Prospective Studies | 3 | 2020 | 1286 | 0.200 |
Why?
|
| Marijuana Abuse | 2 | 2020 | 40 | 0.190 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 305 | 0.190 |
Why?
|
| Quality of Life | 4 | 2007 | 511 | 0.190 |
Why?
|
| Racism | 1 | 2021 | 19 | 0.190 |
Why?
|
| Lactones | 3 | 2017 | 11 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 38 | 0.190 |
Why?
|
| Health Maintenance Organizations | 7 | 2005 | 417 | 0.180 |
Why?
|
| Narration | 1 | 2020 | 7 | 0.180 |
Why?
|
| Risk Factors | 7 | 2019 | 3362 | 0.180 |
Why?
|
| Depressive Disorder, Major | 3 | 2009 | 124 | 0.180 |
Why?
|
| Language | 1 | 2020 | 53 | 0.170 |
Why?
|
| Colonoscopy | 2 | 2020 | 253 | 0.170 |
Why?
|
| Tobacco Use | 1 | 2020 | 15 | 0.170 |
Why?
|
| Adolescent Health Services | 2 | 2001 | 43 | 0.170 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 147 | 0.170 |
Why?
|
| Substance Abuse Detection | 1 | 2020 | 18 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 16 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2021 | 147 | 0.170 |
Why?
|
| Immunochemistry | 1 | 2020 | 18 | 0.170 |
Why?
|
| Dyslipidemias | 1 | 2020 | 62 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 132 | 0.160 |
Why?
|
| Postal Service | 1 | 2020 | 73 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 204 | 0.160 |
Why?
|
| Public Health | 1 | 2020 | 81 | 0.160 |
Why?
|
| Serotonin Uptake Inhibitors | 3 | 2009 | 71 | 0.160 |
Why?
|
| Sertraline | 1 | 2019 | 2 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2017 | 967 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 260 | 0.150 |
Why?
|
| Medicare | 1 | 2020 | 205 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2020 | 673 | 0.150 |
Why?
|
| Occult Blood | 2 | 2016 | 154 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 190 | 0.150 |
Why?
|
| Prognosis | 1 | 2020 | 609 | 0.150 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2019 | 169 | 0.140 |
Why?
|
| Managed Care Programs | 5 | 2007 | 325 | 0.140 |
Why?
|
| Child, Preschool | 4 | 2017 | 1424 | 0.140 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 12 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1120 | 0.140 |
Why?
|
| Metformin | 1 | 2017 | 58 | 0.140 |
Why?
|
| Treatment Outcome | 7 | 2011 | 1265 | 0.130 |
Why?
|
| Remission Induction | 1 | 2016 | 26 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 224 | 0.130 |
Why?
|
| Internet | 3 | 2017 | 231 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 44 | 0.130 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 28 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 3 | 0.120 |
Why?
|
| Microsatellite Instability | 1 | 2015 | 16 | 0.120 |
Why?
|
| Fluorouracil | 1 | 2015 | 11 | 0.120 |
Why?
|
| Adenoma | 1 | 2016 | 94 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 272 | 0.120 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 57 | 0.120 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 51 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2020 | 698 | 0.120 |
Why?
|
| Street Drugs | 1 | 2014 | 13 | 0.110 |
Why?
|
| Smoking Prevention | 1 | 2013 | 54 | 0.100 |
Why?
|
| Diet | 1 | 2014 | 366 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 101 | 0.100 |
Why?
|
| Child of Impaired Parents | 2 | 2002 | 33 | 0.100 |
Why?
|
| Patient Compliance | 2 | 2006 | 301 | 0.100 |
Why?
|
| Depressive Disorder | 2 | 2005 | 222 | 0.100 |
Why?
|
| Dementia | 1 | 2013 | 112 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 1097 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2013 | 193 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 755 | 0.090 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2010 | 24 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2010 | 42 | 0.090 |
Why?
|
| Data Collection | 3 | 2017 | 257 | 0.090 |
Why?
|
| Oregon | 6 | 2006 | 181 | 0.090 |
Why?
|
| Feedback | 1 | 2009 | 19 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2009 | 114 | 0.080 |
Why?
|
| Sex Counseling | 1 | 2008 | 2 | 0.080 |
Why?
|
| Telephone | 2 | 2006 | 161 | 0.080 |
Why?
|
| Unsafe Sex | 1 | 2008 | 19 | 0.080 |
Why?
|
| Organ Size | 1 | 2008 | 16 | 0.080 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 25 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 23 | 0.070 |
Why?
|
| Self Care | 2 | 2005 | 163 | 0.070 |
Why?
|
| Sick Role | 1 | 2006 | 9 | 0.070 |
Why?
|
| Self Concept | 1 | 2006 | 39 | 0.070 |
Why?
|
| Health Status | 3 | 2006 | 299 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2005 | 18 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2005 | 32 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 67 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2004 | 315 | 0.060 |
Why?
|
| Social Support | 1 | 2006 | 207 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2004 | 41 | 0.060 |
Why?
|
| Health Services | 2 | 2004 | 113 | 0.050 |
Why?
|
| Adolescent Behavior | 2 | 2014 | 127 | 0.050 |
Why?
|
| Health Equity | 1 | 2021 | 22 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2002 | 85 | 0.050 |
Why?
|
| Mood Disorders | 1 | 2001 | 19 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 381 | 0.050 |
Why?
|
| Reinforcement, Social | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cognitive Therapy | 1 | 2001 | 1 | 0.050 |
Why?
|
| Community Mental Health Services | 1 | 2001 | 33 | 0.050 |
Why?
|
| Aftercare | 1 | 2001 | 49 | 0.040 |
Why?
|
| Naloxone | 1 | 2020 | 19 | 0.040 |
Why?
|
| Food Analysis | 1 | 1999 | 5 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1999 | 16 | 0.040 |
Why?
|
| Parents | 1 | 2002 | 297 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2005 | 125 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 354 | 0.040 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 1998 | 1 | 0.040 |
Why?
|
| Mediastinoscopy | 1 | 1998 | 5 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 391 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 455 | 0.030 |
Why?
|
| Bias | 1 | 2017 | 103 | 0.030 |
Why?
|
| Colorado | 2 | 2007 | 164 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 22 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 29 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 26 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 44 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 65 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 27 | 0.030 |
Why?
|
| Health Surveys | 2 | 2006 | 261 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 181 | 0.030 |
Why?
|
| White Coat Hypertension | 1 | 2015 | 3 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 15 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 28 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 24 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 11 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 303 | 0.030 |
Why?
|
| Memantine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 4 | 0.030 |
Why?
|
| Sex Factors | 2 | 2006 | 644 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 11 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 38 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2014 | 109 | 0.030 |
Why?
|
| Bupropion | 1 | 2013 | 12 | 0.030 |
Why?
|
| Algorithms | 2 | 2005 | 239 | 0.030 |
Why?
|
| Comorbidity | 2 | 2007 | 597 | 0.030 |
Why?
|
| Life Style | 1 | 2014 | 334 | 0.030 |
Why?
|
| Caregivers | 1 | 2013 | 129 | 0.030 |
Why?
|
| Premature Birth | 1 | 2014 | 137 | 0.030 |
Why?
|
| Decision Making | 1 | 2013 | 184 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2011 | 25 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2011 | 22 | 0.020 |
Why?
|
| Psychotherapy, Group | 2 | 2001 | 26 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2005 | 250 | 0.020 |
Why?
|
| Calcium Compounds | 1 | 2010 | 3 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2010 | 16 | 0.020 |
Why?
|
| Washington | 2 | 2002 | 383 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 40 | 0.020 |
Why?
|
| Lipids | 1 | 2010 | 82 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2010 | 5 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 66 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 71 | 0.020 |
Why?
|
| Prevalence | 2 | 2004 | 888 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 57 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 484 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 76 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2010 | 16 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 166 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2009 | 64 | 0.020 |
Why?
|
| Psychometrics | 1 | 2007 | 121 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 85 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 101 | 0.020 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2006 | 12 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 128 | 0.020 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 2 | 0.020 |
Why?
|
| Respiratory System Agents | 1 | 2005 | 2 | 0.020 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2005 | 3 | 0.020 |
Why?
|
| Birth Order | 1 | 2005 | 6 | 0.020 |
Why?
|
| Food Hypersensitivity | 1 | 2005 | 5 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 15 | 0.020 |
Why?
|
| Medical Audit | 1 | 2005 | 39 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2006 | 223 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2005 | 13 | 0.020 |
Why?
|
| Maternal Age | 1 | 2005 | 77 | 0.020 |
Why?
|
| Cues | 1 | 2005 | 10 | 0.020 |
Why?
|
| Recurrence | 1 | 2005 | 189 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 305 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1335 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 190 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 85 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 246 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 382 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2005 | 229 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 151 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2002 | 36 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2001 | 15 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 48 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 472 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 2001 | 20 | 0.010 |
Why?
|
| Patient Selection | 1 | 2002 | 190 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 300 | 0.010 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2001 | 28 | 0.010 |
Why?
|
| Health Policy | 1 | 2001 | 123 | 0.010 |
Why?
|
| Child Health Services | 1 | 2001 | 113 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2001 | 169 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 86 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 376 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2467 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1998 | 1 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1998 | 8 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 60 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 24 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2001 | 280 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 1931 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 810 | 0.010 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->